These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22456337)

  • 1. Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons.
    Futatsugi A; Utreras E; Rudrabhatla P; Jaffe H; Pant HC; Kulkarni AB
    Cell Cycle; 2012 Apr; 11(8):1603-10. PubMed ID: 22456337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Sox6 by cyclin dependent kinase 5 in brain.
    Rudrabhatla P; Utreras E; Jaffe H; Kulkarni AB
    PLoS One; 2014; 9(3):e89310. PubMed ID: 24662752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator.
    Endo R; Saito T; Asada A; Kawahara H; Ohshima T; Hisanaga S
    J Biol Chem; 2009 Sep; 284(38):26029-39. PubMed ID: 19638632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intermediate Rb-E2F activity state safeguards proliferation commitment.
    Konagaya Y; Rosenthal D; Ratnayeke N; Fan Y; Meyer T
    Nature; 2024 Jul; 631(8020):424-431. PubMed ID: 38926571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.
    He L; Zhang Z; Yu Y; Ahmed S; Cheung NS; Qi RZ
    Cell Mol Life Sci; 2011 May; 68(9):1633-43. PubMed ID: 20976519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.
    Sahlgren CM; Pallari HM; He T; Chou YH; Goldman RD; Eriksson JE
    EMBO J; 2006 Oct; 25(20):4808-19. PubMed ID: 17036052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.
    Tiwari MN; Hall BE; Ton AT; Ghetti R; Terse A; Amin N; Chung MK; Kulkarni AB
    Mol Pain; 2023; 19():17448069231218353. PubMed ID: 37982142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila lacking the Cdk5 activator, p35, display defective axon guidance, age-dependent behavioral deficits and reduced lifespan.
    Connell-Crowley L; Vo D; Luke L; Giniger E
    Mech Dev; 2007 May; 124(5):341-9. PubMed ID: 17368005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk5 phosphorylation-dependent C9orf72 degradation promotes neuronal death in Parkinson's disease models.
    Xu X; Li M; Su Y; Wang Q; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    CNS Neurosci Ther; 2023 Dec; 29(12):3952-3966. PubMed ID: 37353944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three decades of Cdk5.
    Pao PC; Tsai LH
    J Biomed Sci; 2021 Nov; 28(1):79. PubMed ID: 34814918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CDK5/cyclin complexes in ischemia-induced death and survival of renal tubular cells.
    Guevara T; Sancho M; Pérez-Payá E; Orzáez M
    Cell Cycle; 2014; 13(10):1617-26. PubMed ID: 24675881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK5: an oncogene or an anti-oncogene: location location location.
    Nikhil K; Shah K
    Mol Cancer; 2023 Nov; 22(1):186. PubMed ID: 37993880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced Cdk5 activity enhances cytoprotective basal autophagy in
    Nandi N; Tyra LK; Stenesen D; Krämer H
    Elife; 2017 Dec; 6():. PubMed ID: 29227247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTIVATION OF CYCLIN-DEPENDENT KINASE 5 BROADENS ACTION POTENTIALS IN HUMAN SENSORY NEURONS.
    Tiwari MN; Hall BE; Terse A; Amin N; Chung MK; Kulkarni AB
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-canonical functions of the RB protein in cancer.
    Dick FA; Goodrich DW; Sage J; Dyson NJ
    Nat Rev Cancer; 2018 Jul; 18(7):442-451. PubMed ID: 29692417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-free time-resolved terbium luminescence assays designed for cyclin-dependent kinase 5 (CDK5).
    Heier JL; Boselli DJ; Parker LL
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
    Ehrlich SM; Liebl J; Ardelt MA; Lehr T; De Toni EN; Mayr D; Brandl L; Kirchner T; Zahler S; Gerbes AL; Vollmar AM
    J Hepatol; 2015 Jul; 63(1):102-13. PubMed ID: 25660209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk5 regulates multiple cellular events in neural development, function and disease.
    Kawauchi T
    Dev Growth Differ; 2014 Jun; 56(5):335-48. PubMed ID: 24844647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Cdk5 in neuroendocrine thyroid cancer.
    Pozo K; Castro-Rivera E; Tan C; Plattner F; Schwach G; Siegl V; Meyer D; Guo A; Gundara J; Mettlach G; Richer E; Guevara JA; Ning L; Gupta A; Hao G; Tsai LH; Sun X; Antich P; Sidhu S; Robinson BG; Chen H; Nwariaku FE; Pfragner R; Richardson JA; Bibb JA
    Cancer Cell; 2013 Oct; 24(4):499-511. PubMed ID: 24135281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.